Clinical Trials in Salt Lake City

Showing 10261-10280 of 16,694 trials

The Genetics of Polycystic Ovarian Syndrome

NCT00166569

The goal of this study is to determine the genetic basis of polycystic ovary syndrome (PCOS). We will first look for genes in the Icelandic population, where large family trees are known and it is easier to search for genes. We will then determine whether these same genes are important in U.S. PCOS patients.

Polycystic Ovary Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2,700 participantsStarted Jan 2003

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)

NCT02379052

The primary objective of the study is to assess the clinical efficacy of repeat subcutaneous (SC) doses of dupilumab, compared with placebo, to relieve symptoms in adult participants with active, moderate to severe Eosinophilic Esophagitis (EoE). The secondary objectives of the study are: * To assess the safety, tolerability, and immunogenicity of SC doses of dupilumab in adult participants with active, moderate to severe EoE * To assess the effect of dupilumab on esophageal eosinophilic infiltration * To evaluate the pharmacokinetics (PK) of dupilumab in adult participants with EoE

Eosinophilic Esophagitis

Regeneron Pharmaceuticals47 participantsStarted May 2015

Idaho Falls, Idaho, United States • Chicago, Illinois, United States • Urbana, Illinois, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

NCT03456830

The purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria.

Enteric Hyperoxaluria

Allena Pharmaceuticals115 participantsStarted May 2018

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +60 more locations

The Genetics of Polycystic Ovarian Syndrome

Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

Find Trials by Condition in Salt Lake City

Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Intrathecal Mafosfamide

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Patient and Provider Assessment of Lipid Management Registry

Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease